期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | npj Genomic Medicine LetPub Score 7.1
50 ratings
Rate
Reputation 8.3 Influence 6.1 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | NPJ GENOM MED | ||||||||||||||||||||||||
ISSN | 2056-7944 | ||||||||||||||||||||||||
h-index | 11 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 2.10%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.nature.com/npjgenmed | ||||||||||||||||||||||||
在線稿件提交 | https://mts-npjgenmed.nature.com/cgi-bin/main.plex?form_type=home | ||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||
出版商 | Springer Nature | ||||||||||||||||||||||||
主題領域 | Biochemistry, Genetics and Molecular Biology | ||||||||||||||||||||||||
出版國/地區 | United Kingdom | ||||||||||||||||||||||||
發行頻率 | |||||||||||||||||||||||||
創刊年 | 2016 | ||||||||||||||||||||||||
每年文章數 | 36每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 99.03% | ||||||||||||||||||||||||
OA Related Info | APC: Yes( GBP2890; USD3890; EUR3290; ) APC waiver:Check Notes Other charges: No Keywords: pharmacogenomics、genomic medicine、neurogenomics、cancer genomics、gene disorders、epigenomics Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2056-7944%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 17 Weeks | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
首頁 上一頁 1 下一頁 末頁 (頁 | |
[npj Genomic Medicine] 的評論 | 撰寫評論 |
作者: 拂柳统维 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-21 13:50:00 評論於 May I ask about the current status? My manuscript has been Under Consideration for 14 days(0) 讚! | 拂柳统维 |
作者: 孤云春广 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-24 21:04:31 評論於 Can anyone tell me if Manuscript Under Consideration has been assigned to any reviewers? It has been 14 days and the status hasn't changed, is it under external review? I'm getting anxious(0) 讚! | 孤云春广 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:25:52 評論於 If the main part has been completed, it is recommended to start with the results. If the main results are still in progress, you can start with the methods and introduction(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 09:32:17 評論於 Most journals have specific requirements for articles, as well as a checklist that can be used as a reference. You can also refer to articles already published in the target journal for writing(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Darlene Pepys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 20:08:33 評論於 Is there a writing template for SCI articles?(0) 讚! | Darlene Pepys |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 13:13:16 評論於 Why is it recommended to start writing a research article from the results? Is it possible to start writing from the methods section?(0) 讚! | 陶宜三岁啦 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us